GANTRISIN
LOE ApproachingNDAORALTABLET
Approved
Jul 1948
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
GANTRISIN is a legacy oral small-molecule antibiotic approved in 1948 with a sulfanilamide-based mechanism of action. The product is indicated for bacterial infections treatable via oral administration. Its mechanism involves inhibition of bacterial folate synthesis, making it effective against a range of gram-positive and gram-negative organisms.
LOE Approaching
With LOE approaching and moderate competitive pressure (30%), commercial teams face contraction; roles will shift toward optimization and managed transition strategies rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
GANTRISIN offers limited career upside given its LOE-approaching lifecycle and zero linked job openings; roles focus on maintaining market access and managing decline rather than growth. Professionals seeking dynamic career movement should consider this a transitional or portfolio-management assignment.
Product Manager (generic/legacy)Regulatory Affairs Specialist
Worked on GANTRISIN at Roche? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.